Stock listing

NASDAQ:DBTX Decibel Therapeutics Inc Stock

Follow Decibel Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:DBTX

$4.91 USD

Close on Oct 4, 2023 · No longer trades

Feb 12, 2021 to last close -72.8% · weekly closes, Feb 12, 2021 – Oct 4, 2023
Lowest – highest close
$1.85 – $19.90 USDSince Feb 12, 2021 · lowest May 9, 2022 · highest Feb 22, 2021

Delisted NASDAQ:DBTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:DBTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Decibel Therapeutics Inc on 6ix

Decks
1 deck · latest Jan 9, 2023

Decks

DeckKindSlidesDate
41st Annual Healthcare Meeting January 2023Conference28 slidesJan 9, 2023

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Peter Thompson
Other companies: Aspen Neuroscience, Inc. (General Partner · Since at least Nov 2, 2026); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Edgewise Therapeutics, Inc. (Chairman and Co-Founder · Since at least Mar 25, 2021); ARS Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020); Corvus Pharmaceuticals, Inc. (CO-FOUNDER · Since at least Mar 22, 2016); Janux Therapeutics, Inc. (Director · Jun 10, 2021 – Jun 14, 2022 · Past); PMV Pharmaceuticals, Inc. (Director · Sep 24, 2020 – Jun 2, 2021 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Principia Biopharma Inc (Director · Sep 13, 2018 – Sep 13, 2018 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jun 4, 2018 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past); Anthera Pharmaceuticals Inc (Director · Feb 1, 2011 – May 8, 2012 · Past); Trubion Pharmaceuticals Inc (President and CEO, Director · Oct 17, 2006 – Aug 27, 2009 · Past)
Director · Feb 11, 2021 – Jun 17, 2022 · Past
Christine A. Poon
Other companies: Neurocrine Biosciences, Inc. (Director · Since at least Jul 11, 2023); Regeneron Pharmaceuticals, Inc. (Director · Since at least Nov 12, 2010); Prudential Financial, Inc. (Director · Since at least Sep 1, 2006); Sherwin-Williams Company (the) (Director · Apr 16, 2014 – Apr 4, 2025 · Past); Johnson & Johnson (Vice Chairman, Director · Dec 30, 2005 – Feb 12, 2009 · Past)
Director · Feb 11, 2021 – Feb 11, 2021 · Past
Neil Exter
Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Pliant Therapeutics, Inc. (Director · Jun 2, 2020 – Jun 16, 2022 · Past); Revolution Medicines, Inc. (Director · Feb 12, 2020 – Jun 16, 2022 · Past); Rhythm Pharmaceuticals, Inc. (Director · Oct 4, 2017 – Jun 6, 2018 · Past); CytomX Therapeutics, Inc. (Director · Oct 7, 2015 – Jun 20, 2017 · Past)
Director · Feb 11, 2021 – Jun 17, 2022 · Past
James B Murphy
Other companies: Mustang Bio, Inc. (Interim CFO · Jan 19, 2024 – Jan 19, 2024 · Past); Whitehawk Therapeutics, Inc. (See Remarks · Mar 15, 2017 – Mar 15, 2017 · Past); Oncotelic Therapeutics Inc (Chief Financial Officer · Jun 14, 2006 – Sep 15, 2010 · Past)
See Remarks · Oct 7, 2022 – Oct 7, 2022 · Past
Kevin F. McLaughlin
Other companies: Invivyd, Inc. (Director · Since at least May 21, 2024); Vericel Corporation (Director · Since at least Jan 6, 2015); Acceleron Pharma Inc (SVP, CFO and Treasurer · Jul 7, 2015 – Nov 19, 2021 · Past)
Director · Oct 10, 2022 – Sep 25, 2023 · Past
Laurence Reid
Other companies: Metagenomi Therapeutics, Inc. (Director · Since at least Aug 11, 2025); KalVista Pharmaceuticals, Inc. (Director · Since at least Nov 23, 2024); Alnylam Pharmaceuticals, Inc. (SVP, Chief Business Officer · Jun 1, 2010 – Dec 31, 2014 · Past)
See Remarks, Director · Feb 11, 2021 – Sep 25, 2023 · Past
Alison C. Finger
Other companies: ADMA Biologics Inc (Director · Since at least Sep 28, 2023); Bluebird bio Inc (Chief Commercial Officer · Feb 14, 2018 – Jan 5, 2021 · Past)
Director · Dec 3, 2021 – Sep 25, 2023 · Past
Elisabeth Leiderman
Other companies: Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Bluebird bio Inc (Director · Since at least Oct 15, 2021)
Chief Financial Officer · Feb 11, 2021 – Feb 25, 2022 · Past
William H. Carson
Other companies: Annexon, Inc. (BOARD MEMBER · Since at least Feb 5, 2021); Prevail Therapeutics Inc (Director · Sep 9, 2020 – Jan 22, 2021 · Past)
Director · Jun 2, 2021 – Sep 25, 2023 · Past
Cynthia W Hu
Other companies: Definium Therapeutics, Inc. (Chief Legal Officer&Secretary · Jan 1, 2022 – Mar 24, 2022 · Past)
General Counsel · Aug 16, 2021 – Aug 16, 2021 · Past
All 15 people
PersonSeat
Matthew C Kapusta
Other companies: uniQure N.V. (CEO, Managing Director, Director · Since at least Jan 1, 2017)
Director · Mar 19, 2023 – Sep 25, 2023 · Past
Sara Nochur
Other companies: Marinus Pharmaceuticals Inc (Director · Mar 22, 2021 – Jun 18, 2024 · Past)
Director · Dec 3, 2021 – Sep 25, 2023 · Past
Anna TraskChief People Officer · Feb 11, 2021 – Sep 25, 2023 · Past
John Jui-Jen LeeChief Development Officer · Feb 11, 2021 – Sep 25, 2023 · Past
Matthew FoyDirector · Feb 11, 2021 – Feb 17, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Decibel Therapeutics Inc.